Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Hematol ; 88(9): 784-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23757320

ABSTRACT

Aberrant promoter DNA methylation is a well-described mechanism of leukemogenesis within hematologic malignancies, including acute lymphoblastic leukemia (ALL). However, the importance of methylation patterns among the adolescent and young adult (AYA) ALL population has not been well established. DNA methylation of 18 candidate genes in 33 AYA ALL patients was analyzed at diagnosis and during treatment, to evaluate the frequency and clinical relevance of aberrant methylation in an AYA population treated on a uniform therapeutic regimen. Of 16 informative genes, there was a median of 6 methylated genes per AYA ALL patient. Correlations were identified between increasing number of methylated genes with male sex (P = 0.04), increased white blood cell (WBC) count (P = 0.04) and increased bone-marrow blast percentage (P = 0.04). Increasing age was associated with EPHA5 methylation (P = 0.05). Overall, patients experienced favorable outcomes with median survival that was not reached. On univariate analysis, methylation of CYP1B1 was associated with worse overall survival (HR 10.7, 95% CI 1.3-87.6, P = 0.03), disease-free survival (HR 3.7, 95% CI 1.1-9.2, P = 0.04) and correlated with decreased CYP1B1 gene expression. A significant incidence of methylation within the AYA ALL population was identified, with increased methylation associated with distinct clinicopathologic features including male gender and elevated WBC count. Our results suggest aberrant methylation among AYA patients is frequent, and may provide a common pathogenic mechanism. The inferior outcome identified with methylation of the cytochrome p450 gene CYP1B1, an enzyme involved in drug metabolism and steroid synthesis, warrants further investigation.


Subject(s)
Aryl Hydrocarbon Hydroxylases/metabolism , DNA Methylation , DNA/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Adolescent , Adult , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP1B1 , DNA/genetics , Female , Gene Expression , Humans , Leukocyte Count , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Promoter Regions, Genetic , Receptor, EphA5/genetics , Receptor, EphA5/metabolism , Sex Factors , Survival Analysis
2.
Phys Rev Lett ; 103(15): 152002, 2009 Oct 09.
Article in English | MEDLINE | ID: mdl-19905623

ABSTRACT

Azimuthal single-spin asymmetries of leptoproduced pions and charged kaons were measured on a transversely polarized hydrogen target. Evidence for a naive-T-odd, transverse-momentum-dependent parton distribution function is deduced from nonvanishing Sivers effects for pi(+), pi(0), and K(+/-), as well as in the difference of the pi(+) and pi(-) cross sections.

3.
Phys Rev Lett ; 100(21): 210801, 2008 May 30.
Article in English | MEDLINE | ID: mdl-18518594

ABSTRACT

An experiment (E166) at the Stanford Linear Accelerator Center has demonstrated a scheme in which a multi-GeV electron beam passed through a helical undulator to generate multi-MeV, circularly polarized photons which were then converted in a thin target to produce positrons (and electrons) with longitudinal polarization above 80% at 6 MeV. The results are in agreement with GEANT4 simulations that include the dominant polarization-dependent interactions of electrons, positrons, and photons in matter.

4.
Phys Rev Lett ; 96(16): 162301, 2006 Apr 28.
Article in English | MEDLINE | ID: mdl-16712217

ABSTRACT

The first measurements of double-hadron production in deep-inelastic scattering within the nuclear medium were made with the HERMES spectrometer at DESY HERA using a 27.6 GeV positron beam. By comparing data for deuterium, nitrogen, krypton, and xenon nuclei, the influence of the nuclear medium on the ratio of double-hadron to single-hadron yields was investigated. Nuclear effects on the additional hadron are clearly observed, but with little or no difference among nitrogen, krypton, or xenon, and with smaller magnitude than effects seen on previously measured single-hadron multiplicities. The data are compared with models based on partonic energy loss or prehadronic scattering and with a model based on a purely absorptive treatment of the final-state interactions. Thus, the double-hadron ratio provides an additional tool for studying modifications of hadronization in nuclear matter.

5.
Mol Carcinog ; 26(4): 261-73, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10569803

ABSTRACT

The Bloom (BLM) and Werner's (WRN) syndrome proteins may regulate recombination and DNA repair. Using a novel polyclonal antibody to human BLM, we detected the 170-kda BLM antigen in wild-type but not Bloom syndrome cells. BLM was localized to punctate nuclear structures. The level of BLM but not WRN was 3.6 fold-higher in G(1)/S-synchronized fibroblasts than in G(0)-synchronized fibroblasts. BLM-positive cells invariably expressed topoisomerase IIalpha, whereas topoisomerase IIbeta was expressed constitutively. Transfections of BLM deletion mutants demonstrated that the C-terminal domain of BLM mediated nuclear entry and the central helicase domain was necessary for producing the punctate pattern. By subcellular fractionation, BLM was found primarily in high-salt extracts of the nucleoplasm and the nuclear matrix and was enriched in G(1)/S-synchronized cells compared with G(0)-synchronized cells. There was no interaction between BLM and WRN or topoisomerases IIalpha and IIbeta in fibroblasts. These results demonstrate that BLM is targeted to specific nuclear structures and that its expression is enhanced during cell growth. The known nucleolar localization of WRN, its invariant expression during the cell cycle, and the lack of interaction between BLM and WRN suggest distinct roles for BLM and WRN in processes such as DNA repair and recombination.


Subject(s)
Adenosine Triphosphatases/metabolism , Bloom Syndrome/enzymology , Cell Nucleus/enzymology , DNA Helicases/metabolism , Nuclear Matrix/enzymology , Werner Syndrome/enzymology , Adenosine Triphosphatases/genetics , B-Lymphocytes , Bloom Syndrome/genetics , Cell Cycle , Cells, Cultured , DNA Helicases/genetics , Exodeoxyribonucleases , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Library , HeLa Cells , Humans , RecQ Helicases , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Restriction Mapping , Sequence Deletion , Skin/cytology , Skin/metabolism , Transfection , Tumor Cells, Cultured , Werner Syndrome/genetics , Werner Syndrome Helicase
6.
Blood Cells Mol Dis ; 25(5-6): 305-9, 1999.
Article in English | MEDLINE | ID: mdl-10744426

ABSTRACT

The X-linked form of the bone marrow failure syndrome Dyskeratosis congenital is caused by mutations in dyskerin, a 514 amino acid protein that is presumed to play a role in ribosome biogenesis. Here we report that dyskerin tagged with the human immunoglobulin epitope localizes to nuclei of transfected HeLa and COS-1 cells. A carboxyl-terminal domain consisting of amino acids 467-475 and encoding KKEKKKSKK is both necessary and sufficient to mediate nuclear entry. Immunoglobulin-tagged dyskerin did not interact with the Fanconi anemia group A protein, FANCA. These results suggest a nuclear role for dyskerin. Moreover, hematopoietic failure observed in both Dyskeratosis congenital and the most common type of Fanconi anemia is unlikely to have a common mechanism resulting from abnormal physical interactions between the respective gene products of these disorders.


Subject(s)
Affinity Labels , Cell Cycle Proteins/immunology , Cell Cycle Proteins/metabolism , DNA-Binding Proteins , Epitopes/metabolism , Nuclear Proteins/immunology , Nuclear Proteins/metabolism , Animals , COS Cells/ultrastructure , Cell Cycle Proteins/genetics , Dyskeratosis Congenita/genetics , Dyskeratosis Congenita/immunology , Dyskeratosis Congenita/metabolism , Epitopes/immunology , Fanconi Anemia Complementation Group A Protein , HeLa Cells/ultrastructure , Humans , Immunoglobulin G/immunology , Immunoglobulin G/metabolism , Microscopy, Fluorescence , Mutation , Nuclear Localization Signals , Nuclear Proteins/genetics , Protein Binding , Proteins/metabolism , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Subcellular Fractions/chemistry , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...